CLINICAL_TRIALS
trial_result
· 2017-05-23
Clinical Trial Update: Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy [Phase 2]
Summary
Phase 2 trial of lapatinib in women with metastatic breast cancer after failure of prior antihormone therapy; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Kansas Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-05-23